BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30219509)

  • 21. RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation.
    Campos RK; Wong B; Xie X; Lu YF; Shi PY; Pompon J; Garcia-Blanco MA; Bradrick SS
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restriction of Zika virus infection and transmission in Aedes aegypti mediated by an insect-specific flavivirus.
    Romo H; Kenney JL; Blitvich BJ; Brault AC
    Emerg Microbes Infect; 2018 Nov; 7(1):181. PubMed ID: 30429457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-feeding and immunogenic Aedes aegypti saliva proteins.
    Wasinpiyamongkol L; Patramool S; Luplertlop N; Surasombatpattana P; Doucoure S; Mouchet F; Séveno M; Remoue F; Demettre E; Brizard JP; Jouin P; Biron DG; Thomas F; Missé D
    Proteomics; 2010 May; 10(10):1906-16. PubMed ID: 19882664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Aedes-Anopheles Vaccine Candidate Supplemented with BCG Epitopes Against the Aedes and Anopheles Genera to Overcome Hypersensitivity to Mosquito Bites.
    Naveed M; Ali U; Aziz T; Naveed R; Mahmood S; Khan MM; Alharbi M; Albekairi TH; Alasmari AF
    Acta Parasitol; 2024 Mar; 69(1):483-504. PubMed ID: 38194049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterization of a serine protease inhibitor modulated in the infection of the Aedes aegypti with dengue virus.
    Soares TS; Rodriguez Gonzalez BL; Torquato RJS; Lemos FJA; Costa-da-Silva AL; Capurro Guimarães ML; Tanaka AS
    Biochimie; 2018 Jan; 144():160-168. PubMed ID: 29133118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-human primate antibody response to mosquito salivary proteins: Implications for dengue virus transmission in Puerto Rico.
    Hemme RR; Poole-Smith BK; Hunsperger EA; Felix GE; Horiuchi K; Biggerstaff BJ; Lopez-Ortiz R; Barrera R
    Acta Trop; 2016 Dec; 164():369-374. PubMed ID: 27593498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The insect-specific Palm Creek virus modulates West Nile virus infection in and transmission by Australian mosquitoes.
    Hall-Mendelin S; McLean BJ; Bielefeldt-Ohmann H; Hobson-Peters J; Hall RA; van den Hurk AF
    Parasit Vectors; 2016 Jul; 9(1):414. PubMed ID: 27457250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoinformatics designed T cell multi epitope dengue peptide vaccine derived from non structural proteome.
    Krishnan G S; Joshi A; Akhtar N; Kaushik V
    Microb Pathog; 2021 Jan; 150():104728. PubMed ID: 33400987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dengue vaccines for travelers.
    Wilder-Smith A; Deen JL
    Expert Rev Vaccines; 2008 Jul; 7(5):569-78. PubMed ID: 18564012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue and other flavivirus infections.
    Choumet V; Desprès P
    Rev Sci Tech; 2015 Aug; 34(2):473-8, 467-72. PubMed ID: 26601449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of IgE responses using a recombinant mosquito salivary allergen rAed a 2 without adjuvant in mice.
    Wang H; Mao X; Simons FE; Peng Z
    Int Arch Allergy Immunol; 1999 Oct; 120(2):135-40. PubMed ID: 10545767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First screening of Aedes albopictus immunogenic salivary proteins.
    Doucoure S; Cornelie S; Patramool S; Mouchet F; Demettre E; Seveno M; Dehecq JS; Rutee H; Herve JP; Favier F; Missé D; Gasque P; Remoue F
    Insect Mol Biol; 2013 Aug; 22(4):411-23. PubMed ID: 23714164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of Flavivirus with their mosquito vectors and their impact on the human health in the Americas.
    Valderrama A; Díaz Y; López-Vergès S
    Biochem Biophys Res Commun; 2017 Oct; 492(4):541-547. PubMed ID: 28499872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection.
    Pandey RK; Ali M; Ojha R; Bhatt TK; Prajapati VK
    Vaccine; 2018 Jul; 36(30):4555-4565. PubMed ID: 29921492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
    Whitehead SS; Durbin AP; Pierce KK; Elwood D; McElvany BD; Fraser EA; Carmolli MP; Tibery CM; Hynes NA; Jo M; Lovchik JM; Larsson CJ; Doty EA; Dickson DM; Luke CJ; Subbarao K; Diehl SA; Kirkpatrick BD
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005584. PubMed ID: 28481883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vertical Transmission of Zika Virus in Aedes aegypti Mosquitoes.
    Thangamani S; Huang J; Hart CE; Guzman H; Tesh RB
    Am J Trop Med Hyg; 2016 Nov; 95(5):1169-1173. PubMed ID: 27573623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mosquito-Borne Diseases and Omics: Salivary Gland Proteome of the Female Aedes aegypti Mosquito.
    Dhawan R; Kumar M; Mohanty AK; Dey G; Advani J; Prasad TS; Kumar A
    OMICS; 2017 Jan; 21(1):45-54. PubMed ID: 28271980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress and Works in Progress: Update on Flavivirus Vaccine Development.
    Collins MH; Metz SW
    Clin Ther; 2017 Aug; 39(8):1519-1536. PubMed ID: 28754189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
    Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
    J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.